Astragaloside IV reduces cardiac oxidation and improves left ventricular diastolic dysfunction

Back

ESC Premium Access

Astragaloside IV reduces cardiac oxidation and improves left ventricular diastolic dysfunction

Session: Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor Q. Wang (Lanzhou, CN)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Qiongying Wang

Lanzhou University Second Hospital, Lanzhou (China)

0 follower

21 more presentations in this session

Effects of mineralocorticoid receptor antagonists on diastolic function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials

Speaker: Associate Professor H. Fukuta (Nagoya, JP)

Access

Abstract

Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction

Speaker: Doctor K. Kopeva (Tomsk, RU)

Access

Abstract

Slides

Long non coding RNA levels in hypertensive patients with heart failure with preserved ejection fraction and their relation to their functional capacity

Speaker: Associate Professor M. Marketou (Heraklion, GR)

Access

Abstract

Slides

Morphological and functional changes in cardiovascular system in heart failure with preserved ejection fraction.

Speaker: Doctor M. Kurkina (Moscow, RU)

Access

Abstract

Slides

criteria derived from end-systolic pressure-volume relation applied to the study of heart failure

Speaker: Professor R. Shoucri (Kingston, CA)

Access

Abstract

Slides

Access the full session

Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

Speakers: Doctor Q. Wang, Associate Professor H. Fukuta, Doctor K. Kopeva, Associate Professor M. Marketou, Doctor M. Kurkina...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources